Citropten

Citropten

SCHEMBL516577

COc1cc(OC)c2ccc(=O)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 1.00
KDM4E B2RXH2 7/20 1.00
HSD17B10 Q99714 5/20 1.00
HPGD P15428 4/20 1.00
CYP3A4 P08684 3/20 1.00
GLA P06280 1/20 1.00
L3MBTL1 Q9Y468 1/20 1.00
MAOB P27338 1/20 0.68
CYP2A6 P11509 3/20 0.60
MAOA P21397 3/20 0.60
CA12 O43570 3/20 0.57
CA1 P00915 3/20 0.57
CA7 P43166 3/20 0.57
CA9 Q16790 3/20 0.57
CA3 P07451 2/20 0.57
CA4 P22748 2/20 0.57
CA5A P35218 2/20 0.57
CA14 Q9ULX7 2/20 0.57
AKR1B1 P15121 1/20 0.57
CA6 P23280 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citropten SCHEMBL29425178 1.00 ALDH1A1 (1.00) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
Citropten SCHEMBL1259008 0.91 KDM4E (0.83) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL15842385 0.87 KDM4E (0.77) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL11511686 0.86 KDM4E (0.76) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL30803821 0.86 KDM4E (0.76) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL15842471 0.86 KDM4E (0.75) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL14826298 0.83 KDM4E (0.71) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL7837457 0.81 KDM4E (0.69) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL29046813 0.81 ALDH1A1 (0.68) ALDH1A1KDM4EHSD17B10HPGDCYP3A4
SCHEMBL29227420 0.80 KDM4E (0.66) ALDH1A1KDM4EHSD17B10HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 891 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP claimed
US-20260096569-A1 EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES APEEL TECH INC (US) 2026-04-09 US claimed
EP-4709369-A1 LIPOLYTIC AND ANTIADIPOGENIC COUMARIN DERIVATIVES Karl-Franzens-Universität Graz (AT) 2026-03-18 EP claimed
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-01-15 US claimed
US-20260007652-A1 Selective Modulators of AhR-Regulated Transcription and Method for Using Such Modulators to Treat Cancer OREGON STATE UNIVERSITY (US) 2026-01-08 US claimed
US-20250304727-A1 PHOTOINITIATOR PACKAGE COMPRISING PHOSPHINE OXIDE PHOTOINITIATORS, COUMARIN-BASED SENSITIZERS AND AMINE ADDITIVES IGM GROUP B.V. (NL) 2025-10-02 US claimed
EP-4602034-A2 SELECTIVE MODULATORS OF AHR-REGULATED TRANSCRIPTION AND METHOD FOR USING SUCH MODULATORS TO TREAT CANCER Oregon State University (US) 2025-08-20 EP claimed
EP-2603098-B1 METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER FIRMENICH INCORPORATED (US) 2025-08-06 EP claimed
US-20250187036-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2025-06-12 US claimed
US-12311406-B2 Methods for producing optical effect layers comprising magnetic or magnetizable pigment particles and exhibiting one or more indicia SICPA HOLDING SA (CH) 2025-05-27 US claimed
CN-1871209-A Agricultural and horticultural insecticide and method of use thereof MITSUI CHEMICALS INC (JP) 2006-11-29 CN claimed
WO-2006118553-A1 COMPOSITIONS COMPRISING NATURAL AGENTS FOR THE TREATMENT OF HIV-ASSOCIATED OPPORTUNISTIC INFECTIONS AND COMPLICATIONS AND METHODS FOR PREPARING AND USING COMPOSITIONS COMPRISING NATURAL AGENTS WUTOH ANTHONY K (US) 2006-11-09 WO claimed
CN-1850044-A Slow-release injection containing aminoglycoside antibiotics and application thereof SHUAIHUA MEDICINE SCIENCE TECH (CN) 2006-10-25 CN claimed
CN-1843330-A Slow release agent containing aminoglycosides antibiotic and its uses SHANDONG LANJIN BIOTECHNOLOGY (CN) 2006-10-11 CN claimed
US-7098244-B2 Antibacterial agent TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-08-29 US claimed
US-20050266105-A1 Compositions comprising natural agents for the treatment of HIV-associated opportunistic infections and complications and methods for preparing and using compositions comprising natural agents ASHIAGBOR KWAME T 2005-12-01 US claimed
CN-1503675-A Telithromycin suspension with a masked taste ������������� 2004-06-09 CN claimed
US-20040091589-A1 Prevention of synthetic color fading in beverages using botanically derived color stabilizers PEPSICO, INC. 2004-05-13 US claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US claimed
EP-0022188-B1 CO-INITIATOR COMPOSITIONS FOR PHOTOPOLYMERIZATION CONTAINING 3-ACYL-SUBSTITUTED COUMARINS, PHOTOPOLYMERIZABLE COMPOSITION AND PHOTOGRAPHIC ELEMENT EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-10-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050266105-A1 Compositions comprising natural agents for the treatment of HIV-associated opportunistic infections and complications and methods for preparing and using compositions comprising natural agents ZAP70, LSS, ITGAM ALDH1A1 3098/4885KDM4E 4484/4885HSD17B10 3403/4885
US-20260007652-A1 Selective Modulators of AhR-Regulated Transcription and Method for Using Such Modulators to Treat Cancer AHR, YAP1, ARNT ALDH1A1 1860/4885KDM4E 723/4885HSD17B10 476/4885
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA IK, TEX10, INCENP ALDH1A1 1748/4885KDM4E 302/4885HSD17B10 3204/4885
US-20260096569-A1 EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES CYP51A1, ERG28, NISCH ALDH1A1 1286/4885KDM4E 1123/4885HSD17B10 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.